Newsroom

Categories

With approval of the Guideline 4000 LP+ neuromodulation targeting system for sale in Canada, FHC technology will now be available to Canadian neurosurgeons

With approval of the Guideline 4000 LP+ neuromodulation targeting system for sale in Canada, FHC technology will now be available to Canadian neurosurgeons.

FHC’s line of clinical products for recording and stimulating are powerful, user-friendly, and streamlined systems.  The microTargeting™ Guideline 4000 LP+™ offers neurosurgical teams offers the most powerful targeting system on the market in a streamlined, affordable package.  Optimized for clinical use (user-specifiable channel count, streamlined setup, rugged design), the LP+ continues to support high-powered research (fully adjustable digital filters, wideband recording capabilities, straightforward data export and analysis).

Learn more about the Guideline 4000 LP+ by visiting our product page.

Categories

Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Browse through FHC’s wide array of neurosurgical research equipment

View Our Products